The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, mentorship, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

Donate Today

 

The INS Peer-Reviewed Journal

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online. The journal also has social media accounts on Twitter, Facebook, and Instagram.

journal cover

+Submit a Manuscript.+ 


The Neuromodulation Podcast has been developed for our membership to dive into the forefront of today's emerging neuromodulation techniques, insights, and ethical and clinical applications.

Join the multidisciplinary collaboration of medical care providers, scientists, and engineers who are part of the global conversation that's shaping the future of healthcare. 

Subscribe now wherever you get your podcasts.


What is Neuromodulation?

Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

Chronic pain
Movement disorders
Epilepsy
Psychiatric disorders
Brain injury / Stroke 
Cardiovascular disorders
Gastrointestinal disorders
Genitourinary and colorectal disorders
Sensory deficits


If you are not a medical professional
and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Breaking News

Effects of Combined Non-Invasive Brain Stimulation and Brain-Computer Interface on Upper Extremity Motor Function After Stroke: A Systematic Review and Meta-Analysis

October 19, 2026 - Researchers at West China Hospital, Sichuan University, reviewed randomized trials of non-invasive brain stimulation (tDCS or rTMS) added to brain-computer interface (BCI) training for upper-limb recovery after stroke. Seven trials were included, and the main analysis of five studies (124 participants) favored BCI training alone, a difference driven by the tDCS trials that lost significance when one influential trial was excluded; rTMS showed no significant difference. The authors conclude that current evidence does not demonstrate a clear added benefit of brain stimulation as an adjunct to BCI, citing small samples, variable study quality, and moderate to very low certainty of evidence. (Source: Frontiers in Neurology, open access)

Home Transcranial Direct Current Stimulation With Gamified Cognitive Control Training for Depression: A Randomized Clinical Trial

October 19, 2026 - A double-masked randomized trial conducted in Germany, Israel, and Latvia tested home-based transcranial direct current stimulation (tDCS) combined with gamified cognitive control training against sham stimulation plus a control game in 111 adults with major depression. The home protocol proved feasible, but depression scores (MADRS) fell similarly in both groups, with a between-group difference of 0.89 points that was not statistically significant. The authors conclude the findings do not support routine clinical adoption and note the short follow-up and the inability to separate the effects of stimulation from those of training. (Source: JAMA Network Open, open access)

Mayo Clinic Study Finds Measurable Brain Response Within Minutes of Deep Brain Stimulation in Patients With Epilepsy

October 16, 2026 - Researchers at Mayo Clinic used intracranial EEG to examine how deep brain stimulation (DBS) of the thalamus changes communication with other brain regions in nine adults with drug-resistant focal epilepsy. Measurable changes in brain connectivity appeared within about 18 minutes of stimulation, and conventional periodic and nonperiodic stimulation patterns affected thalamic connections with the frontal lobe differently. The authors suggest these responses could eventually serve as an earlier, objective signal of treatment response, but note that the small sample and the lack of a link to long-term seizure reduction mean prospective validation is needed before clinical use. The work was funded in part by the Neurosurgery Research and Education Foundation. (Source: iScience)

Cardiopulmonary Effects of Vagus Nerve Stimulation in Mice

September 21, 2026 - Researchers at the University of Texas at Dallas characterized how vagus nerve stimulation (VNS) of the left versus right cervical vagus nerve affects heart rate and breathing in mice. Stimulation lowered heart and breathing rates in most animals with no difference by sex or stimulated side, and the drop in heart rate was abolished when efferent vagal fibers were cut. The authors suggest the findings support the use of mouse models for studying VNS-related cardiopulmonary effects. (Source: eNeuro, open access)

Simultaneous speech and gesture decoding for multimodal communication in paralysis

September 14, 2026 - A University of California, San Francisco team (Chang lab) reported a brain-computer interface (BCI) in three people with severe paralysis, using an electrode array over the sensorimotor cortex to decode attempted speech and gestures at the same time and animate a digital avatar. Accuracy reached up to 82% when copying gestures alone and 65-70% when gestures and speech were produced together, with conversational accuracy of at least 85% for gestures and 75% for speech. The authors describe the work as a proof of concept and plan to develop a wireless, fully implantable version. (Source: Nature Neuroscience, via NIH Research Matters)

To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs